Moreover, the results of the current study further strengthen the idea that the dysfunction of the insulin signalling pathway crosses with dysfunctions of proteins encoded by genes on HSA21, e.g., DYRK1A and APP, thus contributing to worsening a pre-existing condition defined on a genetic background in the DS brain. The gene discussed is INS; the disease is Dravet syndrome.